Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Mycobacterium tuberculosis cell membrane and energetics target refers to the integrated biochemical pathways and structural components responsible for maintaining the electrochemical gradient and generating ATP in M. tuberculosis [1]. This system includes the electron transport chain (ETC), comprising complexes such as NADH dehydrogenase (NDH-1 and NDH-2), the cytochrome bc1:aa3 oxidase complex, and the F1F0-ATP synthase [2][3]. These components are essential for the survival of the pathogen in both its actively replicating and dormant (non-replicating) states, as the maintenance of a proton motive force is required even when the bacteria are not growing [4]. Drugs targeting this system, most notably bedaquiline, have revolutionized the treatment of multidrug-resistant tuberculosis by specifically inhibiting mycobacterial energy production [5]. Because these targets are often distinct from their human mitochondrial counterparts, they provide a high degree of selectivity, although concerns such as QT prolongation remain a clinical challenge [6].
Inhibition of mycobacterial F1F0-ATP synthase [1]; Inhibition of the cytochrome bc1:aa3 complex (QcrB subunit) [2]; Disruption of the proton motive force and membrane potential [3]; Respiratory poisoning via nitric oxide release [4].
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mycobacterium tuberculosis cell membrane and energetics.